Full Text
PND22 Pharmacoeconomic Assessment of Natalizumab in the Treatment of Multiple Sclerosis

Abstract

Authors

N.V. Matveev A.V. Sabanov

Back to Volume 15, Issue 4
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×